Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial

Arms / Cohorts

Experimental:Cohort A: ROS1 Fusion-positive Tumors (Excluding NSCLC)

Accepting patients

Experimental:Cohort B: NTRK1/2/3 Fusion-positive Tumors

Accepting patients

Experimental:Cohort C: ALK Fusion-positive Tumors (Excluding NSCLC)

Accepting patients

Experimental:Cohort G: MDM2-amplified, TP53 Wild-type Tumors

Accepting patients

Experimental:Cohort L: KRAS G12C-positive Tumors (Excluding NSCLC and CRC)

Accepting patients

Experimental:Cohort M: ATM Loss of Function Tumors

Accepting patients

Experimental:Cohort N: SETD2 Loss of Function Tumors

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(831) 888-0898

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.